189 related articles for article (PubMed ID: 12848404)
41. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
[TBL] [Abstract][Full Text] [Related]
42. Involvement of community pharmacists in public health priorities: A multi-center descriptive survey in Ethiopia.
Erku DA; Mersha AG
PLoS One; 2017; 12(7):e0180943. PubMed ID: 28704478
[TBL] [Abstract][Full Text] [Related]
43. Providing patient care in community pharmacies: practice and research in Finland.
Bell JS; Väänänen M; Ovaskainen H; Närhi U; Airaksinen MS
Ann Pharmacother; 2007 Jun; 41(6):1039-46. PubMed ID: 17504836
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of tobacco use cessation interventions delivered by pharmacy personnel: a systematic review.
Mdege ND; Chindove S
Res Social Adm Pharm; 2014; 10(1):21-44. PubMed ID: 23743504
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
46. The effects of community pharmacy-delivered public health interventions on population health and health inequalities: A review of reviews.
Thomson K; Hillier-Brown F; Walton N; Bilaj M; Bambra C; Todd A
Prev Med; 2019 Jul; 124():98-109. PubMed ID: 30959070
[TBL] [Abstract][Full Text] [Related]
47. Measurement of patient satisfaction with community pharmacy services: a review.
Naik Panvelkar P; Saini B; Armour C
Pharm World Sci; 2009 Oct; 31(5):525-537. PubMed ID: 19588267
[TBL] [Abstract][Full Text] [Related]
48. The effectiveness and impact on performance of pharmacy-related competency development frameworks: A systematic review and meta-analysis.
Udoh A; Bruno-Tomé A; Ernawati DK; Galbraith K; Bates I
Res Social Adm Pharm; 2021 Oct; 17(10):1685-1696. PubMed ID: 33608245
[TBL] [Abstract][Full Text] [Related]
49. Do community pharmacists add value to routine immunization programmes? A review of the evidence from the UK.
Perman S; Kwiatkowska RM; Gjini A
J Public Health (Oxf); 2018 Dec; 40(4):e510-e520. PubMed ID: 29462344
[TBL] [Abstract][Full Text] [Related]
50. Screening for major diseases in community pharmacies: a systematic review.
Ayorinde AA; Porteous T; Sharma P
Int J Pharm Pract; 2013 Dec; 21(6):349-61. PubMed ID: 23683090
[TBL] [Abstract][Full Text] [Related]
51. Quality indicators and community pharmacy services: a scoping review.
Alhusein N; Watson MC
Int J Pharm Pract; 2019 Dec; 27(6):490-500. PubMed ID: 31264751
[TBL] [Abstract][Full Text] [Related]
52. Smoking cessation in community pharmacy practice-a clinical information needs analysis.
Saba M; Bittoun R; Kritikos V; Saini B
Springerplus; 2013; 2():449. PubMed ID: 24058894
[TBL] [Abstract][Full Text] [Related]
53. A systematic review of community pharmacies' staff diagnostic assessment and performance in patient consultations.
Sinopoulou V; Gordon M; Rutter P
Res Social Adm Pharm; 2019 Sep; 15(9):1068-1079. PubMed ID: 30342907
[TBL] [Abstract][Full Text] [Related]
54. The effectiveness of interventions to increase preventive care provision for chronic disease risk behaviours in mental health settings: A systematic review and meta-analysis.
Fehily C; Hodder R; Bartlem K; Wiggers J; Wolfenden L; Dray J; Bailey J; Wilczynska M; Stockings E; Clinton-McHarg T; Regan T; Bowman J
Prev Med Rep; 2020 Sep; 19():101108. PubMed ID: 32477852
[TBL] [Abstract][Full Text] [Related]
55. Healthy hearts--a community-based primary prevention programme to reduce coronary heart disease.
Richardson G; van Woerden HC; Morgan L; Edwards R; Harries M; Hancock E; Sroczynsk S; Bowley M
BMC Cardiovasc Disord; 2008 Jul; 8():18. PubMed ID: 18655720
[TBL] [Abstract][Full Text] [Related]
56. Systematic review to inform the development of a community pharmacy-based intervention for people affected by dementia.
Dann-Reed E; Poland F; Wright D
Int J Pharm Pract; 2020 Jun; 28(3):233-245. PubMed ID: 31621974
[TBL] [Abstract][Full Text] [Related]
57. Pharmacy-based alcohol-misuse services: current perspectives.
Hattingh HL; Tait RJ
Integr Pharm Res Pract; 2017; 7():21-31. PubMed ID: 29732288
[TBL] [Abstract][Full Text] [Related]
58. The detection of influenza virus at the community pharmacy to improve the management of local residents with influenza or influenza-like disease.
Kawachi A; Sakamoto Y; Mouri S; Fukumori M; Kawano R; Murakami T; Sonoda J; Narumi K; Shimodozono Y; Etoh K; Chiyotanda S; Furuie T; Sato K; Fukumori M; Motoya T
J Pharm Health Care Sci; 2017; 3():22. PubMed ID: 28808580
[TBL] [Abstract][Full Text] [Related]
59. Community pharmacy COPD services: what do researchers and policy makers need to know?
Twigg MJ; Wright DJ
Integr Pharm Res Pract; 2017; 6():53-59. PubMed ID: 29354551
[TBL] [Abstract][Full Text] [Related]
60. A Systematic Review of Randomized Controlled Trials of Telehealth and Digital Technology Use by Community Pharmacists to Improve Public Health.
Crilly P; Kayyali R
Pharmacy (Basel); 2020 Aug; 8(3):. PubMed ID: 32759850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
